Drugs that contain Clobazam
1. Sympazan patents expiration
SYMPAZAN's oppositions filed in EPO
SYMPAZAN Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765167 | OTTER PHARMS | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb, 2024
(2 months ago) | |
| US8603514 | OTTER PHARMS | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr, 2024
(22 days ago) | |
| US11541002 | OTTER PHARMS | Oral film compositions and dosage forms having precise active dissolution profiles |
Jan, 2040
(15 years from now) | |
Market Authorisation Date: 01 November, 2018
Treatment: Method of treating seizures
Dosage: FILM;ORAL
More Information on Dosage
SYMPAZAN family patents
